Cerebral Abscess and Empyema

Last updated: January 17, 2026
Table Of Contents

Cerebral abscess

A cerebral abscess is a focal collection of pus within the brain parenchyma (a big pus tumour). Abscesses may occur in single or multiple sites, and the site of collection correlates with the sourc eof infection. Initial infection leads to suppuration and loculation of pus, followed by gliosis and formation of a fibrous capsule. Cerebral abscess presents with focal neurological deficits and signs of raised intracranial pressure. Empiric therapy should not be delayed, however, getting a sample for culture and sensitivity to know the bacteria present is appropriate.

Organisms are commonly introduced via a contiguous spread. Streptococcus and staphylococcus species are the most common bacteria responsible though most infections are polymicrobial.

Site of abscess, source of infection, and likely organism

SiteSource of infectionLikely organism
Frontal lobeSinusitis, dental infection, bacteremia, emolism from infective endocarditisStreptococcus pneumoniae, Anaerobes
Temporal lobe and cerebellumOtitis media, mastoiditis, bacteremia, embolism from infective endocarditisStreptococcsu pneumoniae, Gram negative bacilli, Bacteroides and anaerobes
Parietal lobeBacteremia, embolism from infective endocarditisStreptococcsu pneumoniae, Gram negative bacilli, Bacteroides and anaerobes
Any siteTraumaStaphylococcus aureus

Causative organisms

OrganismPopulation
Streptococcus and staphylococcusMost common cause
KlebsiellaDiabetes
Staphylococcus epidermidisIatrogenic
CandidaImmunocompromised
TuberculosisRare but important in Sub-saharan Africa
  • Risk factors in adults
    • Lung infection
    • Dental abscess
    • Sinusitis
    • Otitis
    • Mastoiditis
    • Endocarditis
  • Risk factors in children
    • Cyanotic heart disease
    • Pulmonary arteriovenous malformation
  • Predisposing factors
    • Diabetes
    • Chronic steroid use
    • Sarcoidosis
    • HIV
    • Immunosuppression
    • Organ transplant
    • Recent cranial or dental procedure
  • Signs and symptoms
    • Fever
    • Headache
    • Nausea
    • Vomiting
    • Meningism
    • Focal neurological deficits (weakness, ataxia, hemiparesis, dyslexia, etc.)
    • Papilledema and signs of raised ICP
    • Seizures
    • Altered mental status
  • Investigations
    • Head CT: The best first diagnostic step to locate the abscess. Will clearly show the abscess
      • Single ring-enhancing lesion typically at the grey-white matter junction and watershed areas
      • Multiple foci of abscesses in case of toxoplasmosis
    • MRI:
      • Ring enhancement
      • Hyperintense on T2
    • Aspiration biopsy: Most accurate test; will show us what causative organism
    • Labs: CBC, ESR, CRP
    • Lumbar puncture: delayed when there are signs of raised ICP. May show features of bacterial meningitis.
  • Differentials for a solitary ring-enhancing lesion (MAGICAL DR)
    • Metastasis
    • Abscess
    • Glioblastoma
    • Infarct
    • Contusion
    • Aneurysm
    • Lymphoma
    • Demyelinating disease
    • Radiation necrosis
  • Treatment
    • Empiric IV antibiotics while preparing for surgery or until lesions decrease to < 1cm on MRI. A minimum of 6 – 8 weeks antibiotics is given. Antibiotics have to penetrate the blood brain barrier and capsule. Commonly metronidazole + ceftriaxone + vancomycin
      • IV oxacillin OR nafcillin OR vancomycin OR linezolid – cover staphylococcus
      • IV penicilln G: cover streptococcis
      • IV clindamycin OR metronidazole – cover anaerobes. Clindamycin has poor CNS penetration compared to metronidazole
      • IV 3rd gen cephalosporin (Ceftriaxone, Cefotaxime) – cover gram negatives and Streptococcus
      • IV ceftazidime OR cefepime OR carbapenems – for nosocomial infection or neurosurgery to cover drug resistant gram negative
    • If the patient has AIDS (presumed toxoplasmosis)
      • Pyrimethamine AND Sulfadiazine (Surgery not necessary, will respond in 10-14 days)
      • If they do not respond, exclude abscess and consider a CNS lymphoma
    • Surgical drainage if the abscess if > 2.5 cm, mass effect, signs of raised ICP or clinical deterioration
    • Antiepileptic agents in the acute and peri-operative period (abscesses commonly cause seizures, especially those in the frontal and temporal lobe)
    • Short courseo of glucocorticoids if there is significant mass effect
    Erythromycin, tetracyclins, and first-generation cephalosporins are not recommended due to poor CNS penetration,
  • Indications for surgery for brain abscess
    • Abscess > 2.5 cm
    • Mass effect
    • Signs of raised ICP
    • Clinical deterioration

Empyema

An empyema is a collection of purulent material, commonly in the subdural space. It can also occur in the epidural space. They were historically referred to as abscesses, but the term empyema is preferred now. The clinical presentation is similar to meningitis. A subdural empyema is a surgical emergency. Antibiotics alone won’t control infection.

  • Risk factors
    • ENT infection (sinusitis, otitis, mastoiditis)
    • Skull trauma
    • Neurosurgical procedure
    • Meningitis
  • Signs and symptoms
    • Fever
    • Headache
    • Vomiting
    • Altered mental status
    • Seizure
  • Investigations
    • CT or MRI: diagnostic method of choice. It may be difficult to locate a collection in the posterior fossa on CT.
      • Crescent or elliptical collection of hypo intensity on T1 MRI
      • Mass effect or midline shift may be present
    • Aspirate for culture and sensitivity
  • Treatment
    • IV broad spectrum antibiotics for at least 6-8 weeks
    • Surgical drainage
    • Anti-epileptic medication for seizure prophylaxis
    • Craniectomy and extension of duration of antibiotics if there is adjacent osteomyelitis
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *